Table 7.
Concomitant non-psychiatric medication at baseline (FAS, N = 642)
| Medication | n (%) |
|---|---|
| None | 502 (78.44%) |
| Statins | 12 (1.88%) |
| Other hypolipidemic drugs | 8 (1.25%) |
| Beta-blockers | 62 (9.69%) |
| Diuretics | 24 (3.75%) |
| Ca-antagonists | 10 (1.56%) |
| ACE-inhibitors | 32 (5.00%) |
| Angiotensin-II-antagonists | 2 (0.31%) |
| Other antihypertensive drugs | 22 (3.44%) |
| Insulins | 9 (1.41%) |
| Oral anti-diabetic drugs | 23 (3.59%) |
| Oral corticosteroids | 1 (0.16%) |
| Corticosteroid inhalants | 3 (0.47%) |
Abbreviations: ACE-inhibitors = angiotensin-converting enzyme inhibitors; FAS = full analysis set